Parallax Volatility Advisers, L.P. Karuna Therapeutics, Inc. Transaction History

Parallax Volatility Advisers, L.P.

  • $43.7 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$161.01 - $317.85 $23,829 - $47,041
148 New
148 $46,000
Q4 2022

Feb 14, 2023
BUY
$191.53 - $236.82 $6.17 Million - $7.63 Million
32,199 Added 1065.13%
35,222 $6.92 Million
Q3 2022

Nov 14, 2022
BUY
$123.79 - $277.42 $374,217 - $838,640
3,023 New
3,023 $680,000

Others Institutions Holding KRTX

# of Institutions
13
Shares Held
333K
Call Options Held
0
Put Options Held
0
View Full List

About Karuna Therapeutics, Inc.

KRTX Quotes by TradingView
  • Ticker KRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,965,000
  • Description
  • Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...
More about KRTX
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email